ALLIED CAPITAL BUYS INSIGHT PHARMACEUTICALS

Allied Capital finished its buyout of Insight Pharmaceuticals on Dec. 31, 2004, following an investment of roughly $155 million in the maker of nonprescription medications. Allied Capital, which buys controlling stakes in closely held companies and lends them money in the form of subordinated debt, said Insight is based in Blue Bell, Pa. In a press release, Allied Capital said Insight is known as the maker of, among other things, Anacin pain reliever and Sucrets brand throat lozenges.

iWon (http://money.iwon.com/jsp/nw/nwdt_rt.jsp?cat=USMARKET&src=704&feed=dji§ion=news&news_id=dji-00043020050104&date=20050104&alias=/alias/money/cm/nw)